Multimodal Analgesic Strategies for Cancer-Related Oral Mucositis #450

Blakaj A , Bonomi M , Gamez ME , et al. Oral mucositis in head and neck cancer: Evidence-based management and review of clinical trial data. Oral Oncol, 2019; 95:29–34; doi: 10.1016/j.oraloncology.2019.05.013

Ling IS , Larsson B . Individualized pharmacological treatment of oral mucositis pain in patients with head and neck cancer receiving radiotherapy. Support Care Cancer Sep, 2011; 19(9):1343–1350; doi: 10.1007/s00520-010-0955-1

Hashibe M , Brennan P , Chuang S-c , et al. Interaction between tobacco and alcohol use and the risk of head and neck cancer: Pooled analysis in the international head and neck cancer epidemiology consortium. Cancer Epidemiol Biomarkers Prev, 2009; 18(2):541–550; doi: 10.1158/1055-9965.EPI-08-0347

Neilson K , Pollard A , Boonzaier A , et al. A longitudinal study of distress (depression and anxiety) up to 18 months after radiotherapy for head and neck cancer. Psychooncology, 2013; 22(8):1843–1848; doi: 10.1002/pon.3228

Webster LR . Risk factors for opioid-use disorder and overdose. Anesth Analg, 2017; 125(5):1741–1748; doi: 10.1213/ANE.0000000000002496

Lalla RV , Bowen J , Barasch A . MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer, 2014; 120(10):1453–1461; doi: 10.1002/cncr.28592

Alsubaie HM , Alsini AY , Alsubaie KM , et al. Glutamine for prevention and alleviation of radiation-induced oral mucositis in patients with head and neck squamous cell cancer: Systematic review and meta-analysis of controlled trials. Head Neck, 2021; 43(10):3199–3213; doi: 10.1002/hed.26798

Elad S , Cheng KKF , Lalla RV , et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer, 2020; 126(19):4423–4431.

Brown TJ , Gupta A . Management of cancer therapy-associated oral mucositis. Cancer, 2020; 126(19):4423–4431; doi: 10.1002/cncr.33100

Lowry S . When management of cancer-related pain is complicated by coexisting opioid use disorder: A case review. J Hosp Palliat Nurs, 2022; 24(2):112–118; doi: 10.1097/NJH.0000000000000828

Mercadante S , Bruera E . Methadone as a first-line opioid in cancer pain management: A systematic review. J Pain Symptom Manage, 2018; 55(3):998–1003; doi: 10.1016/j.jpainsymman.2017.10.017

Haumann J , van Kuijk SMJ , Geurts JW , et al. Methadone versus fentanyl in patients with radiation-induced nociceptive pain with head and neck cancer: A randomized controlled noninferiority trial. Pain Pract, 2018; 18(3):331–340; doi: 10.1111/papr.12609

Hermann GM , Iovoli AJ , Platek AJ , et al. A single-institution, randomized, pilot study evaluating the efficacy of gabapentin and methadone for patients undergoing chemoradiation for head and neck squamous cell cancer. Cancer, 2020; 126(7):1480–1491; doi: 10.1002/cncr.32676

Haumann J , Geurts JW , van Kuijk SM , et al. Methadone is superior to fentanyl in treating neuropathic pain in patients with head-and-neck cancer. Eur J Cancer, 2016; 65:121–129; doi: 10.1016/j.ejca.2016.06.025

Pergolizzi J , Aloisi AM , Dahan A , et al. Current knowledge of buprenorphine and its unique pharmacological profile. Pain Pract, 2010; 10(5):428–450; doi: 10.1111/j.1533-2500.2010.00378.x

U.S. Food and Drug Administration. FDA warns about dental problems with buprenorphine medicines dissolved in the mouth to treat opioid use disorder and pain. Silver Spring, MD; 2022. Available from: https://www.fda.gov/media/155352/download [Last accessed: June 8, 2022].

Huscher A , De Stefani A , Smussi I , et al. Transdermal buprenorphine for oropharyngeal mucositis-associated pain in patients treated with radiotherapy for head and neck cancer. J Palliat Med, 2010; 13(4):357–358; doi: 10.1089/jpm.2009.0356

Menten J , Carpentier I , Deschutter H , et al. The use of transdermal buprenorphine to relieve radiotherapy-related pain in head and neck cancer patients. Cancer Invest, 2013; 31(6):412–420; doi: 10.3109/07357907.2013.800094

Vokurka S , Skardova J , Karas M , et al. Oropharyngeal mucositis pain treatment with transdermal buprenorphine in patients after allogeneic stem cell transplantation. J Pain Symptom Manage, 2010; 39(6):e4–e6; doi: 10.1016/j.jpainsymman.2010.02.003

Russo L , Meliambro N , Ipek S , et al. Prophylaxis of severe oral mucositis with tramadole and buprenorphine in patients with lymphoproliferative diseases undergoing high-dose chemotherapy with autologous haematopoietic progenitor cells rescue: A single centre experience. Bone Marrow Transplant, 2009; 43:S358.

Smith DK , Cmelak A , Niermann K , et al. Preventive use of gabapentin to decrease pain and systemic symptoms in patients with head and neck cancer undergoing chemoradiation. Head Neck, 2020; 42(12):3497–3505; doi: 10.1002/hed.26407

Bar Ad V , Weinstein G , Dutta PR , et al. Gabapentin for the treatment of pain related to radiation-induced mucositis in patients with head and neck tumors treated with intensity-modulated radiation therapy. Head Neck, 2010; 32(2):173–177; doi: 10.1002/hed.21165

Starmer HM , Yang W , Raval R , et al. Effect of gabapentin on swallowing during and after chemoradiation for oropharyngeal squamous cell cancer. Dysphagia, 2014; 29(3):396–402; doi: 10.1007/s00455-014-9521-1

Raval R , Richardson M , Kumar R , et al. Gabapentin therapy for prevention and management of the pain syndrome in oropharyngeal carcinoma patients treated with radiation: A retrospective study. Int J Radiat Oncol Biol Phys, 2012; 84(3):S651; doi: 10.1016/j.ijrobp.2012.07.1739

Cook A , Modh A , Ali H , et al. Randomized phase 3, double-blind, placebo-controlled study of prophylactic gabapentin for the reduction of oral mucositis pain during the treatment of oropharyngeal squamous cell carcinoma. Int J Radiat Oncol Biol Phys, 2022; 112(4):926–937; doi: 10.1016/j.ijrobp.2021.11.012

Cerchietti LC , Navigante AH , Körte MW , et al. Potential utility of the peripheral analgesic properties of morphine in stomatitis-related pain: A pilot study. Pain, 2003; 105(1–2):265–273; doi: 10.1016/s0304-3959(03)00227-6

Saunders DP , Rouleau T , Cheng K , et al. Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer, 2020; 28(5):2473–2484; doi: 10.1007/s00520-019-05181-6

Sio TT , Le-Rademacher JG , Leenstra JL , et al. Effect of doxepin mouthwash or diphenhydramine-lidocaine-antacid mouthwash vs placebo on radiotherapy-related oral mucositis pain: The alliance A221304 randomized clinical trial. JAMA, 2019; 321(15):1481–1490; doi: 10.1001/jama.2019.3504